Rule 2.7, 3.10.3, 3.10.4, 3.10.5
New issue announcement, application for quotation of additional securities and agreementInformation or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity |
ANALYTICA LIMITED |
ABN |
12 006 464 866 |
We (the entity) give ASX the following information.
Part 1 - All issuesYou must complete the relevant sections (attach sheets if there is not enough space).
1 | +Class of +securities issued or to be issued |
|
2 | Number of +securities issued or to be issued (if known) or maximum number which may be issued | In accordance with the renounceable pro rata entitlement offer (Entitlement Offer) announced to the market on 18 September 2017, the following equities have been issued from the shortfall: (a) 3,000,000 shares;
|
3 | Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) | Shares Fully paid ordinary shares. January Options January Options are exercisable at $0.005 per option expiring on 31 January 2018 and will not be listed. May Options May Options are exercisable at $0.005 per option expiring on 31 May 2018 and will not be listed. |
4 | Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities? If the additional +securities do not rank equally, please state:
| Shares The ordinary shares issued rank equally with all existing fully paid ordinary shares from the issue date. Options Shares will be issued on the exercise of the January Options and May Options and will rank equally with all other fully paid shares. |
5 | Issue price or consideration | $0.005 for each Share and attaching one January Option and one May Option. |
6 | Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) | The capital raised from the allotment of shortfall shares will be used to fund development costs in connection with the PeriCoach System and general working capital purposes. |
6a | Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i | Yes |
6b | The date the security holder resolution under rule 7.1A was passed | 24 November 2016 |
6c | Number of +securities issued without security holder approval under rule 7.1 |
|
6d | Number of +securities issued with security holder approval under rule 7.1A | Nil |
6e | Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) | Nil |
6f | Number of +securities issued under an exception in rule 7.2 |
|
6g | If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation. | N/A |
6h | If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements | N/A |
6i | Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements | Rule 7.1 remaining capacity - 395,396,400 Rule 7.1A remaining capacity - 280,597,600 |
7 | +Issue dates Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. | 31 October 2017 |
Number | +Class |
2,818,976,003 119,372,193 | Ordinary Shares Options - expiring 28 February 2018 at 1.4 cents |
Number | +Class |
Options 269,839,671 269,839,671 44,500,000 5,000,000 6,350,000 10,416,667 14,000,000 72,500,000 41,000,000 33,350,000 | Options Expiring 31/01/2018 at 0.5 cents Expiring 31/05/2018 at 0.5 cents Expiring 29/10/2018 at 3.22 cents Expiring 12/02/2019 at 4.39 cents Expiring 22/05/2019 at 7.33 cents Expiring 28/02/2020 at 1.9 cents Expiring 9/12/2020 at 1.62 cents Expiring 22/12/2021 at 1.3 cents Expiring 8/6/2022 at 1.3 cents Expiring 8/6/2022 at 1.036 cents |
Number and +class of all
+securities quoted on ASX (including the +securities in section 2 if applicable)
Number and +class of all
+securities not quoted on ASX (including the +securities in section 2 if applicable)
Unchanged
Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)
11 | Is security holder approval required? |
12 | Is the issue renounceable or non- renounceable? |
13 | Ratio in which the +securities will be offered |
14 | +Class of +securities to which the offer relates |
15 | +Record date to determine entitlements |
Analytica Limited published this content on 31 October 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 31 October 2017 01:27:06 UTC.
Original documenthttp://www.analyticamedical.com/downloads/2017/20171031-ASX-ALT-Appendix3B.pdf
Public permalinkhttp://www.publicnow.com/view/E460559E673DAAFE71DC635CC8CC3E4AB04BDBB0